Page last updated: 2024-12-07

6-hydroxynorketamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

6-hydroxynorketamine: RN given refers to parent cpd without isomeric designation; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID133669
CHEMBL ID3544557
SCHEMBL ID19400466
MeSH IDM0144531

Synonyms (14)

Synonym
6vad9sc8nw ,
unii-6vad9sc8nw
6-hydroxynorketamine
cyclohexanone, 2-amino-2-(2-chlorophenyl)-6-hydroxy-
81395-70-2
2-amino-2-(2-chlorophenyl)-6-hydroxycyclohexan-1-one
hydroxynorketamine
CHEMBL3544557
SCHEMBL19400466
Q20164362
BCP23645
2r-6r-hnk
(2r,6r) 6-hydroxynorketamine pound>>(2r,6r)-2-amino-2-(2-chlorophenyl)-6-hydroxycyclohexan-1-one;cis-6-hydroxy-norketamine
DTXSID701001963

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
"To construct a population pharmacokinetic (popPK) model for ketamine (Ket), norketamine (norKet), dehydronorketamine (DHNK), hydroxynorketamine (2S,6S;2R,6R)-HNK) and hydroxyketamine (HK) in patients with treatment-resistant bipolar depression."( Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression.
Brutsche, NE; Ibrahim, L; Luckenbaugh, DA; Mager, DE; Moaddel, R; Venkata, SL; Wainer, IW; Zarate, CA; Zhao, X, 2012
)
0.38

Dosage Studied

ExcerptRelevanceReference
" Ketamine dosing was studied up to 20 mg/kg intravenously for the single-dose neuropathology study and up to 60 mg/kg intraperitoneally for the multiple-dose neuropathology study."( A comparison of the pharmacokinetics and NMDAR antagonism-associated neurotoxicity of ketamine, (2R,6R)-hydroxynorketamine and MK-801.
Burke, RD; Elayan, I; Gould, TD; Lemke-Boutcher, LE; Lynch, DC; Mathew, S; Moaddel, R; Morris, PJ; Rao, DB; Sharma, AK; Thomas, CJ; Zanos, P; Zarate, CA,
)
0.13
" Our findings also provide additional support for the importance of dosing frequency in establishing the cognitive effects of repeated ketamine exposure."( (R,S)-ketamine and (2R,6R)-hydroxynorketamine differentially affect memory as a function of dosing frequency.
An, X; Gould, TD; Pereira, EFR; Riggs, LM, 2021
)
0.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (37)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (2.70)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's13 (35.14)24.3611
2020's23 (62.16)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 16.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index16.05 (24.57)
Research Supply Index3.71 (2.92)
Research Growth Index4.58 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (16.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (5.26%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other36 (94.74%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]